SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$370,000
-76.1%
3,680
-66.3%
0.01%
-75.0%
Q2 2021$1,547,000
-54.2%
10,930
-60.0%
0.03%
-54.8%
Q4 2020$3,380,000
+253.9%
27,340
+179.0%
0.06%
+121.4%
Q3 2020$955,000
-24.4%
9,800
+21.0%
0.03%
-53.3%
Q2 2020$1,264,0008,1000.06%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders